Copanlisib
Product Specifications
CAS Number
1032568-63-0
Target
PI3K, Apoptosis
Related Pathways
PI3K/Akt/mTOR signaling, Apoptosis
Purity
0.9988
Bioactivity
Copanlisib (BAY 80-6946) is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. By inhibiting the PI3K signaling pathway, Copanlisib may impede tumor cell growth and survival in certain tumor populations. Dysregulated PI3K signaling, often linked to tumorigenesis, may also contribute to tumor resistance to various antineoplastic agents.
Smiles
O(C)C1=C2C(C=3N(C(NC(=O)C=4C=NC(N)=NC4)=N2)CCN3)=CC=C1OCCCN5CCOCC5
Molecular Formula
C23H28N8O4
Molecular Weight
480.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
585041-01 20 µg
Interleukin-20 Receptor Subunit beta, Recombinant, Human, aa30-233, His-Tag
Sign In for Pricing
View Details 585041-02 100 µg
Interleukin-20 Receptor Subunit beta, Recombinant, Human, aa30-233, His-Tag
Sign In for Pricing
View Details 585041-03 1 mg
Interleukin-20 Receptor Subunit beta, Recombinant, Human, aa30-233, His-Tag
Sign In for Pricing
View Details